Goldman Sachs
ACGN

Goldman Sachs’s Aceragen Inc ACGN Stock Holding History

Goldman Sachs’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,316
Closed -$41K – 6787
2021
Q3 		$41K Buy
2,316
+786
+51% +$14.2K ﹤0.01% 6084
2021
Q2 		$31K Buy
+1,530
New +$30.8K ﹤0.01% 6121
2021
Q1 		– Sell
-1,375
Closed -$86K – 6439
2020
Q4 		$86K Buy
+1,375
New +$78.9K ﹤0.01% 5316
2019
Q4 		– Sell
-897
Closed -$44K – 5460
2019
Q3 		$44K Sell
897
-30
-3% -$1.32K ﹤0.01% 5059
2019
Q2 		$42K Buy
+927
New +$43.9K ﹤0.01% 5022
2018
Q4 		– Sell
-2,924
Closed -$442K – 5792
2018
Q3 		$442K Sell
2,924
-1,016
-26% -$145K ﹤0.01% 4490
2018
Q2 		$707K Buy
3,940
+3,351
+569% +$782K ﹤0.01% 4297
2018
Q1 		$147K Buy
589
+306
+108% +$83.9K ﹤0.01% 5147
2017
Q4 		$81K Buy
283
+200
+241% +$57.1K ﹤0.01% 5813
2017
Q3 		$25K Sell
83
-340
-80% -$88.9K ﹤0.01% 6401
2017
Q2 		$99K Buy
423
+127
+43% +$33.2K ﹤0.01% 6123
2017
Q1 		$99K Buy
+296
New +$71.4K ﹤0.01% 6066
2016
Q4 		– Sell
-445
Closed -$155K – 7151
2016
Q3 		$155K Buy
445
+195
+78% +$51.6K ﹤0.01% 5986
2016
Q2 		$52K Sell
250
-34
-12% -$7.5K ﹤0.01% 6412
2016
Q1 		$76K Buy
284
+72
+34% +$19.2K ﹤0.01% 6224
2015
Q4 		$89K Sell
212
-2,374
-92% -$1.06M ﹤0.01% 6247
2015
Q3 		$1.18M Buy
2,586
+1,355
+110% +$599K ﹤0.01% 4307
2015
Q2 		$621K Buy
1,231
+513
+71% +$235K ﹤0.01% 4972
2015
Q1 		$362K Buy
+718
New +$438K ﹤0.01% 5463
2014
Q4 		– Sell
-74
Closed -$23K – 7366
2014
Q3 		$23K Sell
74
-729
-91% -$262K ﹤0.01% 6971
2014
Q2 		$316K Sell
803
-172
-18% -$70.9K ﹤0.01% 5771
2014
Q1 		$540K Buy
+975
New +$667K ﹤0.01% 5218

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's ACGN Position: Q4 2021 in Review

Goldman Sachs sold out of Aceragen Inc (ACGN) in Q4 2021, closing a stake of 2,316 shares — an estimated $41K sold.

Goldman Sachs first reported a position in ACGN in Q1 2014 and held it in 22 quarters. The position peaked at $1.18M in Q3 2015. 34 funds tracked by Wall St. Rank hold ACGN as of Q4 2021.

  • Goldman Sachs reported no remaining Aceragen Inc position as of Q4 2021 after selling out during the quarter.
  • Goldman Sachs sold 2,316 Aceragen Inc shares in Q4 2021, an estimated $41K.
  • Goldman Sachs first reported a position in Aceragen Inc in Q1 2014 and held it in 22 quarters.
  • Goldman Sachs's Aceragen Inc position peaked at $1.18M in Q3 2015.
  • 34 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.